What Happened?
Temecula, California-based Rev.1 Engineering® - A subsidiary of ASAHI Filmecc. Promoted Andy Denison as Chief Technology Officer
About the Company
Since 2007, Rev.1 Engineering® has been a leading provider of innovative solutions to global medical device companies. With an experienced team of 20+ engineers and technicians boasting an industry average of over 20 years, we specialize in developing novel technologies and delivery systems for complex, interventional therapies that drive exponential value in the marketplace. Recently acquired by ASAHI INTECC, we now operate as a subsidiary under ASAHI Filmecc. Our areas of expertise include: - Structural Heart and Delivery Systems - Interventional Cardiology - Drug/Device/Biologics Combination Products - Neuromodulation Devices - Catheter Navigation, Delivery, and Anchoring Systems - Design for Manufacture & Design Transfer - Rapid Operational Improvements (Profitability of Current Manufacturing Lines) - Remediation (Engineering & Documentation) Throughout our journey, we have successfully developed 140+ devices for over 70 client companies, including startups with limited budgets and tight deadlines. Operating in this challenging environment has honed Rev.1 into an efficient and effective medical device development and innovation company, consistently proving to be 2X Faster than in-house development. Our rapid speed to market translates into a distinct competitive and financial advantage for our clients.
About the Person
Andy Denison is Chief Technology Officer at Rev.1 Engineering® - A subsidiary of ASAHI Filmecc.. Previously, Andy held various senior IT leadership roles in the industry.
Info Source
News
Short Profile